BEHAVIORAL SENSITIZATION IN 6-HYDROXYDOPAMINE LESIONED RATS INVOLVES THE DOPAMINE SIGNAL-TRANSDUCTION - CHANGES IN DARPP-32 PHOSPHORYLATION

被引:36
作者
BARONE, P [1 ]
MORELLI, M [1 ]
POPOLI, M [1 ]
CICARELLI, G [1 ]
CAMPANELLA, G [1 ]
DICHIARA, G [1 ]
机构
[1] UNIV CAGLIARI,DEPT TOXICOL,CAGLIARI,ITALY
关键词
D O I
10.1016/0306-4522(94)90409-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
''Priming'' is a phenomenon of behavioural sensitization observed in unilaterally 6-hydroxy-dopamine lesioned rats following exposure to a dopamine agonist. After priming, a single dose of the D-1 agonist SKF 38393 (3 mg/kg) produces contralateral turning, while the same dose is inactive in drug-naive, lesioned animals. The molecular mechanisms of ''priming'' were investigated here by studying the phosphorylation of dopamine and adenosine 3'-5' monophosphate regulated phosphoprotein (DARPP-32), a dopamine- and cyclic AMP-regulated phosphoprotein functionally linked to D-1 receptors in striatum. Dephospho-form of DARPP-32 was measured by a back-phosphorylation assay. All assays were performed in striata from both lesioned and unlesioned sides. A significant decrease of dephospho-DARPP-32 (27%) was observed in the denervated striatum of primed rats, indicating an increased phosphorylation in vivo of DARPP-32 in response to the D-1 agonist. The levels of DARPP-32 protein. as measured by quantitative immunoblotting, remained unchanged in all experimental groups. This study shows that priming is expressed as an increased transduction of the D-1 receptor message.
引用
收藏
页码:867 / 873
页数:7
相关论文
共 36 条
[1]  
[Anonymous], 1979, STEREOTAXIC ATLAS RA
[2]   DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS [J].
BARONE, P ;
BANKIEWICZ, KS ;
CORSINI, GU ;
KOPIN, IJ ;
CHASE, TN .
NEUROLOGY, 1987, 37 (10) :1592-1595
[3]  
BEITNERJOHNSON D, 1992, ANN NY ACAD SCI, V684, P71
[4]  
BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675
[5]   SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE [J].
BRAUN, A ;
FABBRINI, G ;
MOURADIAN, MM ;
SERRATI, C ;
BARONE, P ;
CHASE, TN .
JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) :41-50
[6]   DOPAMINE D-1 RECEPTOR AND CYCLIC AMP-DEPENDENT PHOSPHORYLATION IN PARKINSONS-DISEASE [J].
CASH, R ;
RAISMAN, R ;
PLOSKA, A ;
AGID, Y .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (04) :1075-1083
[7]   INVIVO MODULATION OF STRIATAL PHOSPHOPROTEINS BY DOPAMINERGIC AGENTS [J].
DILUCA, M ;
CIMINO, M ;
ABBRACCHIO, MP ;
CATTABENI, F .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (4-5) :321-328
[9]   STRIATAL PHOSPHOPROTEINS IN PARKINSON DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY [J].
GIRAULT, JA ;
RAISMANVOZARI, R ;
AGID, Y ;
GREENGARD, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) :2493-2497
[10]  
GUITART X, 1982, J NEUROCHEM, V59, P1164